|
Treatment of hypertriglyceridemia and other conditions using LXR modulators
 X0Patent Application No. 60201601, Filed May 3, 2000
X0Patent Application No. 09848990, Filed May 3, 2001
A1Application Publication No. 20020048572, Issued April 25, 2002
T2k Kinase Assays
X0Patent Application No. 60186047, Filed March 1, 2000
X0Patent Application No. 09524435, Filed March 13, 2000
B1Utility Patent No. 6365366, Issued April 2, 2002
Solid Phase Synthesis Of Lxr Ligands
X0Patent Application No. 60194911, Filed April 5, 2000
X0Patent Application No. 09827837, Filed April 4, 2001
A1Application Publication No. 20020072073, Issued June 13, 2002
Solid Phase Synthesis Of Lxr Ligands
B2Utility Patent No. 6673543, Issued January 6, 2004
Solid phase synthesis of LXR ligands
X0Patent Application No. 10749530, Filed December 30, 2003
A1Application Publication No. 20040152132, Issued August 5, 2004
Combination Therapeutic Compositions And Method Of Use
X0Patent Application No. 60201613, Filed May 3, 2000
X0Patent Application No. 09847887, Filed May 2, 2001
A1Application Publication No. 20020037928, Issued March 28, 2002
Combination Therapeutic Compositions And Method Of Use
B2Utility Patent No. 6653332, Issued November 25, 2003
Combination therapeutic compositions and method of use
X0Patent Application No. 10456932, Filed June 5, 2003
A1Application Publication No. 20040259918, Issued December 23, 2004
Stat Modulators
X0Patent Application No. 60246876, Filed November 8, 2000
X0Patent Application No. 10008244, Filed November 7, 2001
A1Application Publication No. 20020151504, Issued October 17, 2002
Stat Modulators
B2Utility Patent No. 6884782, Issued April 26, 2005
STAT modulators
X0Patent Application No. 11014344, Filed December 14, 2004
A1Application Publication No. 20050101540, Issued May 12, 2005
Antiinflammation Agents
X0Patent Application No. 60243581, Filed October 26, 2000
X0Patent Application No. 10004287, Filed October 23, 2001
A1Application Publication No. 20020161004, Issued October 31, 2002
Antiinflammation Agents
B2Utility Patent No. 6846834, Issued January 25, 2005
Antiinflammation Agents
X0Patent Application No. 10928784, Filed August 26, 2004
A1Application Publication No. 20050043330, Issued February 24, 2005
Antiinflammation Agents
B2Utility Patent No. 7186841, Issued March 6, 2007
Ns5b Hcv Polymerase Inhibitors
X0Patent Application No. 60194912, Filed April 5, 2000
X0Patent Application No. 09828270, Filed April 5, 2001
A1Application Publication No. 20020142290, Issued October 3, 2002
Ns5b Hcv Polymerase Inhibitors
B2Utility Patent No. 6727267, Issued April 27, 2004
Fxr Modulators
X0Patent Application No. 60230585, Filed September 5, 2000
X0Patent Application No. 60258092, Filed December 22, 2000
X0Patent Application No. 09945293, Filed August 31, 2001
A1Application Publication No. 20020120137, Issued August 29, 2002
Fxr Modulators
B2Utility Patent No. 6777446, Issued August 17, 2004
Fxr Modulators
X0Patent Application No. 10794228, Filed March 4, 2004
A1Application Publication No. 20040176426, Issued September 9, 2004
Fxr Modulators
B2Utility Patent No. 7511043, Issued March 31, 2009
Sitosterolemia Susceptibility Gene (ssg): Compositions And Methods Of Use
X0Patent Application No. 60198465, Filed April 18, 2000
X0Patent Application No. 60204234, Filed May 15, 2000
X0Patent Application No. 09837992, Filed April 18, 2001
A1Application Publication No. 20020081687, Issued June 27, 2002
Sitosterolemia Susceptibility Gene (ssg): Compositions And Methods Of Use
B2Utility Patent No. 7033810, Issued April 25, 2006
Nik-knockout Mice
X0Patent Application No. 09706236, Filed November 2, 2000
B1Utility Patent No. 6822138, Issued November 23, 2004
Novel receptors
X0Patent Application No. 60213461, Filed June 23, 2000
X0Patent Application No. 09891138, Filed June 25, 2001
A1Application Publication No. 20030083245, Issued May 1, 2003
Quinolinyl And Benzothiazolyl Modulators
X0Patent Application No. 60214810, Filed June 28, 2000
X0Patent Application No. 09894980, Filed June 27, 2001
A1Application Publication No. 20020169185, Issued November 14, 2002
Quinolinyl And Benzothiazolyl Modulators
B2Utility Patent No. 6583157, Issued June 24, 2003
Quinolinyl And Benzothiazolyl Modulators
X0Patent Application No. 10278851, Filed October 21, 2002
A1Application Publication No. 20030171399, Issued September 11, 2003
Quinolinyl And Benzothiazolyl Modulators
X0Patent Application No. 10719997, Filed November 20, 2003
A1Application Publication No. 20040176409, Issued September 9, 2004
Quinolinyl And Benzothiazolyl Modulators
B2Utility Patent No. 7601841, Issued October 13, 2009
Substituted Pyrido[2,3-d]pyrimidines And Methods For Their Use
X0Patent Application No. 60255241, Filed December 11, 2000
X0Patent Application No. 60296499, Filed June 6, 2001
X0Patent Application No. 10015532, Filed December 11, 2001
A1Application Publication No. 20020169159, Issued November 14, 2002
Substituted Pyrido[2,3-d]pyrimidines And Methods For Their Use
B2Utility Patent No. 6964967, Issued November 15, 2005
Substituted Quinazolin-4(3h)-one Compounds, Compositions, And Methods For Their Use
X0Patent Application No. 10231895, Filed August 29, 2002
A1Application Publication No. 20030055054, Issued March 20, 2003
Substituted Quinazolin-4(3h)-one Compounds, Compositions, And Methods For Their Use
B2Utility Patent No. 7053215, Issued May 30, 2006
Cxcr3 Antagonists
X0Patent Application No. 10164690, Filed June 6, 2002
A1Application Publication No. 20030069234, Issued April 10, 2003
Cxcr3 Antagonists
B2Utility Patent No. 6794379, Issued September 21, 2004
Cxcr3 Antagonists
X0Patent Application No. 10946935, Filed September 21, 2004
A1Application Publication No. 20050075333, Issued April 7, 2005
Cxcr3 Antagonists
B2Utility Patent No. 7067662, Issued June 27, 2006
Hydrazones And Analogs As Cholesterol Lowering Agents
X0Patent Application No. 60186249, Filed March 1, 2000
X0Patent Application No. 09798247, Filed March 1, 2001
A1Application Publication No. 20010056096, Issued December 27, 2001
Hydrazones And Analogs As Cholesterol Lowering Agents
B2Utility Patent No. 6605615, Issued August 12, 2003
Diagnosis And Treatment Of Cancer Using Mammalian Pellino Polypeptides And Polynucleotides
X0Patent Application No. 60259502, Filed January 2, 2001
X0Patent Application No. 10041030, Filed December 28, 2001
A1Application Publication No. 20020150934, Issued October 17, 2002
Diagnosis And Treatment Of Cancer Using Mammalian Pellino Polypeptides And Polynucleotides
B2Utility Patent No. 7115368, Issued October 3, 2006
Lometrexol combination therapy
X0Patent Application No. 60254030, Filed December 6, 2000
X0Patent Application No. 60261134, Filed January 11, 2001
X0Patent Application No. 10010740, Filed December 5, 2001
A1Application Publication No. 20020156023, Issued October 24, 2002
Combination Therapy Using Pentafluorobenzenesulfonamides And Antineoplastic Agents
X0Patent Application No. 60245878, Filed November 3, 2000
X0Patent Application No. 10052905, Filed November 2, 2001
A1Application Publication No. 20020177548, Issued November 28, 2002
Combination Therapy Using Pentafluorobenzenesulfonamides And Antineoplastic Agents
B2Utility Patent No. 6822001, Issued November 23, 2004
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
X0Patent Application No. 10977364, Filed October 29, 2004
X0Patent Application No. 10997784, Filed November 23, 2004
A1Application Publication No. 20050250854, Issued November 10, 2005
Abcg8 Vectors, Host Cells, And Method Of Making
X0Patent Application No. 60252235, Filed November 20, 2000
X0Patent Application No. 60253645, Filed November 28, 2000
X0Patent Application No. 09989981, Filed November 20, 2001
A1Application Publication No. 20030049730, Issued March 13, 2003
Abcg8 Vectors, Host Cells, And Method Of Making
B2Utility Patent No. 6821750, Issued November 23, 2004
Novel receptors
X0Patent Application No. 60252841, Filed November 22, 2000
X0Patent Application No. 09990940, Filed November 21, 2001
A1Application Publication No. 20030027252, Issued February 6, 2003
Novel receptors
X0Patent Application No. 11038360, Filed January 18, 2005
A1Application Publication No. 20050170397, Issued August 4, 2005
Prc17: An Amplified Cancer Gene
X0Patent Application No. 60257636, Filed December 22, 2000
X0Patent Application No. 60279554, Filed March 28, 2001
X0Patent Application No. 60267615, Filed February 8, 2001
X0Patent Application No. 10071838, Filed February 8, 2002
A1Application Publication No. 20030044814, Issued March 6, 2003
Methods of using pyrimidine-based antiviral agents
X0Patent Application No. 60261377, Filed January 12, 2001
X0Patent Application No. 60280696, Filed March 29, 2001
X0Patent Application No. 60269778, Filed February 16, 2001
X0Patent Application No. 10078246, Filed February 14, 2002
A1Application Publication No. 20030130264, Issued July 10, 2003
Novel receptors
X0Patent Application No. 60276649, Filed March 16, 2001
X0Patent Application No. 10094417, Filed March 8, 2002
A1Application Publication No. 20030045685, Issued March 6, 2003
Amplified cancer gene WIP1
X0Patent Application No. 60268362, Filed February 14, 2001
X0Patent Application No. 10073123, Filed February 12, 2002
A1Application Publication No. 20030032027, Issued February 13, 2003
Amplified cancer gene hepsin
X0Patent Application No. 60268361, Filed February 14, 2001
X0Patent Application No. 10073060, Filed February 12, 2002
A1Application Publication No. 20030049645, Issued March 13, 2003
Polypeptides And Nucleic Acids Associated With Cancer
X0Patent Application No. 09850948, Filed May 7, 2001
A1Application Publication No. 20030059770, Issued March 27, 2003
Polypeptides And Nucleic Acids Associated With Cancer
B2Utility Patent No. 6919176, Issued July 19, 2005
Polypeptides and nucleic acids associated with cancer
X0Patent Application No. 10273575, Filed October 18, 2002
A1Application Publication No. 20030108931, Issued June 12, 2003
Therapeutic agent for hyperlipidemia
X0Patent Application No. 09782535, Filed February 13, 2001
A1Application Publication No. 20020119958, Issued August 29, 2002
Fused Heterocyclic Compounds
X0Patent Application No. 60288665, Filed May 4, 2001
X0Patent Application No. 10138279, Filed May 3, 2002
A1Application Publication No. 20030023085, Issued January 30, 2003
Fused Heterocyclic Compounds
B2Utility Patent No. 6858619, Issued February 22, 2005
Fused Heterocyclic Compounds
X0Patent Application No. 10289933, Filed November 6, 2002
A1Application Publication No. 20030176694, Issued September 18, 2003
Fused Heterocyclic Compounds
B2Utility Patent No. 6809104, Issued October 26, 2004
Fused Heterocyclic Compounds
X0Patent Application No. 10928029, Filed August 26, 2004
A1Application Publication No. 20050148617, Issued July 7, 2005
Fused Heterocyclic Compounds
B2Utility Patent No. 7125885, Issued October 24, 2006
Modulation of CCR4 function
X0Patent Application No. 60293781, Filed May 23, 2001
X0Patent Application No. 09975566, Filed October 11, 2001
A1Application Publication No. 20020173524, Issued November 21, 2002
Modulation Of Ccr4 Function
X0Patent Application No. 10654112, Filed September 2, 2003
A1Application Publication No. 20040039035, Issued February 26, 2004
Modulation Of Ccr4 Function
B2Utility Patent No. 7262204, Issued August 28, 2007
Ccr4 Antagonists
X0Patent Application No. 10155605, Filed May 22, 2002
A1Application Publication No. 20030018022, Issued January 23, 2003
Ccr4 Antagonists
B2Utility Patent No. 7144903, Issued December 5, 2006
Bis-aryl Thiazole Derivatives
X0Patent Application No. 60302193, Filed June 29, 2001
X0Patent Application No. 10481218, Filed July 12, 2004
A1Application Publication No. 20050215608, Issued September 29, 2005
Bis-aryl Thiazole Derivatives
B2Utility Patent No. 7358267, Issued April 15, 2008
Novel receptors
X0Patent Application No. 60302800, Filed July 3, 2001
X0Patent Application No. 10188405, Filed July 1, 2002
A1Application Publication No. 20030082585, Issued May 1, 2003
Amplified oncogenes and their involvement in cancer
X0Patent Application No. 60314655, Filed August 27, 2001
X0Patent Application No. 60330797, Filed October 31, 2001
X0Patent Application No. 60340863, Filed December 19, 2001
X0Patent Application No. 60375027, Filed April 25, 2002
X0Patent Application No. 10228264, Filed August 27, 2002
A1Application Publication No. 20030092042, Issued May 15, 2003
Amplified gene involved in cancer
X0Patent Application No. 10228263, Filed August 27, 2002
A1Application Publication No. 20030099985, Issued May 29, 2003
Linked Biaryl Compounds
X0Patent Application No. 60322556, Filed September 14, 2001
X0Patent Application No. 60335434, Filed November 30, 2001
X0Patent Application No. 60378627, Filed May 7, 2002
X0Patent Application No. 60386833, Filed June 6, 2002
X0Patent Application No. 10244063, Filed September 13, 2002
A1Application Publication No. 20030149108, Issued August 7, 2003
Linked Biaryl Compounds
B2Utility Patent No. 6869975, Issued March 22, 2005
Linked Biaryl Compounds
X0Patent Application No. 10939918, Filed August 20, 2004
A1Application Publication No. 20080161351, Issued July 3, 2008
Linked Biaryl Compounds
B2Utility Patent No. 7645779, Issued January 12, 2010
Benzimidazole Derivatives
X0Patent Application No. 60327818, Filed October 9, 2001
X0Patent Application No. 10268412, Filed October 9, 2002
A1Application Publication No. 20030144286, Issued July 31, 2003
Benzimidazole Derivatives
B2Utility Patent No. 7132438, Issued November 7, 2006
Gene amplification and overexpression in cancer
X0Patent Application No. 60331394, Filed November 15, 2001
X0Patent Application No. 10287806, Filed November 5, 2002
A1Application Publication No. 20030148341, Issued August 7, 2003
Inflammation Modulators
X0Patent Application No. 60337460, Filed December 5, 2001
X0Patent Application No. 10314428, Filed December 4, 2002
A1Application Publication No. 20030181472, Issued September 25, 2003
Inflammation Modulators
B2Utility Patent No. 7176314, Issued February 13, 2007
Arylsulfonamidobenzylic Compounds
X0Patent Application No. 60353497, Filed January 30, 2002
X0Patent Application No. 10354922, Filed January 29, 2003
A1Application Publication No. 20030229093, Issued December 11, 2003
Arylsulfonamidobenzylic Compounds
B2Utility Patent No. 7071358, Issued July 4, 2006
Identification of an amplified gene and target for drug intervention
X0Patent Application No. 60341436, Filed December 20, 2001
X0Patent Application No. 10318410, Filed December 13, 2002
A1Application Publication No. 20030175763, Issued September 18, 2003
Heterocyclic Arylsulfonamidobenzylic Compounds
X0Patent Application No. 60353496, Filed January 30, 2002
X0Patent Application No. 10354923, Filed January 29, 2003
A1Application Publication No. 20030220339, Issued November 27, 2003
Heterocyclic Arylsulfonamidobenzylic Compounds
B2Utility Patent No. 7112606, Issued September 26, 2006
Gene Amplification In Cancer
X0Patent Application No. 60365206, Filed March 19, 2002
X0Patent Application No. 60365192, Filed March 19, 2002
X0Patent Application No. 10390191, Filed March 18, 2003
A1Application Publication No. 20040005596, Issued January 8, 2004
Gene Amplification In Cancer
B2Utility Patent No. 6974672, Issued December 13, 2005
Amplification and overexpression of oncogenes
X0Patent Application No. 60382606, Filed May 24, 2002
X0Patent Application No. 60398099, Filed July 25, 2002
X0Patent Application No. 10443108, Filed May 22, 2003
A1Application Publication No. 20040005615, Issued January 8, 2004
Receptor Ligands And Methods Of Modulating Receptors
X0Patent Application No. 60424093, Filed November 5, 2002
X0Patent Application No. 10703145, Filed November 5, 2003
B1Utility Patent No. 7056685, Issued June 6, 2006
Amplification and overexpression of oncogenes
X0Patent Application No. 60401342, Filed August 7, 2002
X0Patent Application No. 60434381, Filed December 19, 2002
X0Patent Application No. 10623810, Filed July 22, 2003
A1Application Publication No. 20050059011, Issued March 17, 2005
Antiinflammation Agents
X0Patent Application No. 60422531, Filed October 31, 2002
X0Patent Application No. 10666857, Filed September 19, 2003
A1Application Publication No. 20040097485, Issued May 20, 2004
Antiinflammation Agents
B2Utility Patent No. 7199119, Issued April 3, 2007
Piperidine Derivatives
X0Patent Application No. 60413335, Filed September 24, 2002
X0Patent Application No. 10669606, Filed September 23, 2003
A1Application Publication No. 20040142956, Issued July 22, 2004
Piperidine Derivatives
B2Utility Patent No. 7045527, Issued May 16, 2006
Amplified genes involved in cancer
X0Patent Application No. 60427202, Filed November 19, 2002
X0Patent Application No. 60434434, Filed December 19, 2002
X0Patent Application No. 10715117, Filed November 18, 2003
A1Application Publication No. 20040171037, Issued September 2, 2004
Receptor Ligands And Methods Of Modulating Receptors
X0Patent Application No. 60421142, Filed November 25, 2002
X0Patent Application No. 60444153, Filed January 30, 2003
X0Patent Application No. 10719692, Filed November 21, 2003
B1Utility Patent No. 7189524, Issued March 13, 2007
Fused Bicyclic Nitrogen-containing Heterocycles
X0Patent Application No. 60428600, Filed November 22, 2002
X0Patent Application No. 10720844, Filed November 21, 2003
A1Application Publication No. 20040209871, Issued October 21, 2004
Fused Bicyclic Nitrogen-containing Heterocycles
B2Utility Patent No. 7244727, Issued July 17, 2007
Fused Heterocyclic Compounds
X0Patent Application No. 60424456, Filed November 6, 2002
X0Patent Application No. 10705173, Filed November 6, 2003
A1Application Publication No. 20040147538, Issued July 29, 2004
Fused Heterocyclic Compounds
B2Utility Patent No. 7253179, Issued August 7, 2007
Asthma And Allergic Inflammation Modulators
X0Patent Application No. 60435366, Filed December 20, 2002
X0Patent Application No. 10742281, Filed December 19, 2003
A1Application Publication No. 20040220237, Issued November 4, 2004
Asthma And Allergic Inflammation Modulators
B2Utility Patent No. 7321001, Issued January 22, 2008
CXCR3 antagonists
X0Patent Application No. 60451157, Filed February 27, 2003
X0Patent Application No. 10789165, Filed February 26, 2004
A1Application Publication No. 20040242498, Issued December 2, 2004
Pyrrolo[1,2-b]pyridazine Derivatives
X0Patent Application No. 60493997, Filed August 7, 2003
X0Patent Application No. 10913307, Filed August 6, 2004
A1Application Publication No. 20050070545, Issued March 31, 2005
Pyrrolo[1,2-b]pyridazine Derivatives
B2Utility Patent No. 7300932, Issued November 27, 2007
Gene amplification and overexpression in cancer
X0Patent Application No. 60462702, Filed April 15, 2003
X0Patent Application No. 10817418, Filed April 5, 2004
A1Application Publication No. 20050004059, Issued January 6, 2005
Gene amplification and overexpression in cancer
X0Patent Application No. 60531924, Filed December 22, 2003
X0Patent Application No. 60515537, Filed October 28, 2003
X0Patent Application No. 60479833, Filed June 20, 2003
X0Patent Application No. 10867183, Filed June 15, 2004
A1Application Publication No. 20050026194, Issued February 3, 2005
Arylsulfonamidobenzylic compounds
X0Patent Application No. 60494692, Filed August 12, 2003
X0Patent Application No. 10916868, Filed August 11, 2004
A1Application Publication No. 20060264424, Issued November 23, 2006
Asthma and allergic inflammation modulators
X0Patent Application No. 60485978, Filed July 9, 2003
X0Patent Application No. 10887341, Filed July 7, 2004
A1Application Publication No. 20050038070, Issued February 17, 2005
Salts And Polymorphs Of A Potent Antidiabetic Compound
X0Patent Application No. 60508470, Filed October 3, 2003
X0Patent Application No. 10956251, Filed October 1, 2004
A1Application Publication No. 20050143416, Issued June 30, 2005
Salts And Polymorphs Of A Potent Antidiabetic Compound
B2Utility Patent No. 7223761, Issued May 29, 2007
Novel Eukaryotic Transcription Protein: Host Cell Factor
X0Patent Application No. 60523463, Filed November 19, 2003
X0Patent Application No. 60524050, Filed November 24, 2003
X0Patent Application No. 60583682, Filed June 29, 2004
X0Patent Application No. 60583898, Filed June 29, 2004
X0Patent Application No. 60548741, Filed February 27, 2004
X0Patent Application No. 60601579, Filed August 12, 2004
X0Patent Application No. 60601578, Filed August 12, 2004
X0Patent Application No. 60564376, Filed April 20, 2004
X0Patent Application No. 60551656, Filed March 8, 2004
X0Patent Application No. 60556013, Filed March 23, 2004
X0Patent Application No. 60563251, Filed April 14, 2004
X0Patent Application No. 60583823, Filed June 28, 2004
X0Patent Application No. 60583901, Filed June 28, 2004
X0Patent Application No. 60583822, Filed June 28, 2004
X0Patent Application No. 60601223, Filed August 13, 2004
X0Patent Application No. 07989842, Filed December 4, 1992
X0Patent Application No. 08046585, Filed April 12, 1993
B1Utility Patent No. 5453362, Issued September 26, 1995
Inhibitors Of Apoptosis
X0Patent Application No. 08246977, Filed May 20, 1994
X0Patent Application No. 08270653, Filed July 5, 1994
X0Patent Application No. 08269604, Filed July 5, 1994
X0Patent Application No. 08494006, Filed June 23, 1995
X0Patent Application No. 08512946, Filed August 8, 1995
X0Patent Application No. 10934717, Filed September 3, 2004
A1Application Publication No. 20050037416, Issued February 17, 2005
Inhibitors Of Apoptosis
B2Utility Patent No. 6964765, Issued November 15, 2005
Rip: Novel Human Protein Involved In Tumor Necrosis Factor Signal Transduction
X0Patent Application No. 08553727, Filed October 23, 1995
X0Patent Application No. 09758003, Filed January 9, 2001
A1Application Publication No. 20020098522, Issued July 25, 2002
Rip: Novel Human Protein Involved In Tumor Necrosis Factor Signal Transduction
B2Utility Patent No. 7029871, Issued April 18, 2006
Pentafluorobenzenesulfonamides And Analogs
X0Patent Application No. 08605431, Filed February 22, 1996
X0Patent Application No. 60022198, Filed July 19, 1996
X0Patent Application No. 09972743, Filed October 5, 2001
A1Application Publication No. 20020143036, Issued October 3, 2002
Pentafluorobenzenesulfonamides And Analogs
B2Utility Patent No. 7138418, Issued November 21, 2006
Pentafluorobenzenesulfonamides And Analogs
X0Patent Application No. 10270259, Filed October 11, 2002
A1Application Publication No. 20030162817, Issued August 28, 2003
Pentafluorobenzenesulfonamides And Analogs
B2Utility Patent No. 6962929, Issued November 8, 2005
Regulators Of Apoptosis
X0Patent Application No. 60013981, Filed March 22, 1996
X0Patent Application No. 09861270, Filed May 18, 2001
A1Application Publication No. 20020052474, Issued May 2, 2002
Regulators Of Apoptosis
B2Utility Patent No. 7528244, Issued May 5, 2009
Cell-based Drug Screens For Regulators Of Gene Expression
X0Patent Application No. 10365958, Filed February 13, 2003
A1Application Publication No. 20030153025, Issued August 14, 2003
Cell-based Drug Screens For Regulators Of Gene Expression
B2Utility Patent No. 7105313, Issued September 12, 2006
Ikk-alpha Proteins, Nucleic Acids And Methods
X0Patent Application No. 08882606, Filed June 25, 1997
X0Patent Application No. 08887114, Filed July 1, 1997
X0Patent Application No. 08887115, Filed July 1, 1997
X0Patent Application No. 10243408, Filed September 13, 2002
A1Application Publication No. 20030077683, Issued April 24, 2003
Ikk-alpha Proteins, Nucleic Acids And Methods
B2Utility Patent No. 7045613, Issued May 16, 2006
Nuclear Hormone Receptor Drug Screens
X0Patent Application No. 09163713, Filed September 30, 1998
B1Utility Patent No. 7101681, Issued September 5, 2006
Ppargamma Modulators
X0Patent Application No. 60067708, Filed December 8, 1997
X0Patent Application No. 60075005, Filed February 17, 1998
X0Patent Application No. 60071137, Filed January 13, 1998
X0Patent Application No. 60073042, Filed January 29, 1998
X0Patent Application No. 10123298, Filed April 15, 2002
A1Application Publication No. 20030088103, Issued May 8, 2003
Ppargamma Modulators
B2Utility Patent No. 7439242, Issued October 21, 2008
Human uncoupling protein-2 (hCP2): compositions and methods of use
X0Patent Application No. 60075224, Filed February 19, 1998
X0Patent Application No. 09052841, Filed March 31, 1998
X0Patent Application No. 60092098, Filed July 8, 1998
X0Patent Application No. 60090681, Filed June 25, 1998
X0Patent Application No. 09336062, Filed June 18, 1999
X0Patent Application No. 60093570, Filed July 20, 1998
X0Patent Application No. 09130858, Filed August 7, 1998
X0Patent Application No. 09124293, Filed July 29, 1998
X0Patent Application No. 09884814, Filed June 18, 2001
A1Application Publication No. 20020127600, Issued September 12, 2002
Arylsulfonanilide Ureas
X0Patent Application No. 60100888, Filed September 23, 1998
X0Patent Application No. 10387217, Filed March 11, 2003
A1Application Publication No. 20030207864, Issued November 6, 2003
Arylsulfonanilide Ureas
B2Utility Patent No. 7060718, Issued June 13, 2006
CANDIDA ALBICANS mRNA 5'-TRIPHOSPHATASE (CET-1) POLYNUCLEOTIDES
X0Patent Application No. 09178358, Filed October 23, 1998
X0Patent Application No. 60112613, Filed December 17, 1998
X0Patent Application No. 09213678, Filed December 17, 1998
A1Application Publication No. 20020018774, Issued February 14, 2002
FXR receptor-mediated modulation of cholesterol metabolism
X0Patent Application No. 60115249, Filed January 7, 1999
X0Patent Application No. 10217293, Filed August 12, 2002
A1Application Publication No. 20030003520, Issued January 2, 2003
Lxr Modulators
X0Patent Application No. 60115292, Filed January 8, 1999
X0Patent Application No. 09479315, Filed January 6, 2000
B1Utility Patent No. 6906069, Issued June 14, 2005
Compounds For The Modulation Of Ppary Activity
X0Patent Application No. 60116392, Filed January 19, 1999
X0Patent Application No. 60124525, Filed March 15, 1999
X0Patent Application No. 60141672, Filed June 30, 1999
X0Patent Application No. 09606433, Filed June 28, 2000
B1Utility Patent No. 7041691, Issued May 9, 2006
Compounds For The Modulation Of Ppary Activity
X0Patent Application No. 10810325, Filed March 25, 2004
A1Application Publication No. 20040248882, Issued December 9, 2004
Compounds For The Modulation Of Ppary Activity
B2Utility Patent No. 7626033, Issued December 1, 2009
High-throughput screening assays for modulators of mitochondrial membrane potential
X0Patent Application No. 60133268, Filed May 10, 1999
X0Patent Application No. 09567856, Filed May 9, 2000
A1Application Publication No. 20030170606, Issued September 11, 2003
Methods Of Assaying For Compounds That Inhibit Premature Translation Termination And Nonsense-mediated Rna Decay
X0Patent Application No. 60146436, Filed July 29, 1999
X0Patent Application No. 60159236, Filed October 13, 1999
X0Patent Application No. 10226803, Filed August 21, 2002
A1Application Publication No. 20030008317, Issued January 9, 2003
Methods Of Assaying For Compounds That Inhibit Premature Translation Termination And Nonsense-mediated Rna Decay
B2Utility Patent No. 7026122, Issued April 11, 2006
Chandra: A Th1-specific Protein
X0Patent Application No. 60161201, Filed October 22, 1999
X0Patent Application No. 10308373, Filed December 2, 2002
A1Application Publication No. 20030175265, Issued September 18, 2003
Chandra: A Th1-specific Protein
B2Utility Patent No. 6956105, Issued October 18, 2005
Nucleic Acid Encoding Kcnb Potassium Channel
X0Patent Application No. 60186915, Filed March 3, 2000
X0Patent Application No. 09798584, Filed March 2, 2001
A1Application Publication No. 20020102676, Issued August 1, 2002
Nucleic Acid Encoding Kcnb Potassium Channel
B2Utility Patent No. 7462465, Issued December 9, 2008
Irak-4: Compositions And Methods Of Use
X0Patent Application No. 60176395, Filed January 13, 2000
X0Patent Application No. 10990276, Filed November 15, 2004
A1Application Publication No. 20050255549, Issued November 17, 2005
Irak-4: Compositions And Methods Of Use
B2Utility Patent No. 7235635, Issued June 26, 2007
Antibacterial Agents
X0Patent Application No. 60175892, Filed January 13, 2000
X0Patent Application No. 10877408, Filed June 25, 2004
A1Application Publication No. 20040235911, Issued November 25, 2004
Antibacterial Agents
B2Utility Patent No. 7053234, Issued May 30, 2006
Car modulators: screening and treatment of hypercholesterolemia
X0Patent Application No. 60176398, Filed January 13, 2000
X0Patent Application No. 09760364, Filed January 12, 2001
A1Application Publication No. 20020152479, Issued October 17, 2002
Novel G-protein Coupled Receptors
X0Patent Application No. 60176000, Filed January 12, 2000
X0Patent Application No. 60201988, Filed May 3, 2000
X0Patent Application No. 10633894, Filed August 4, 2003
A1Application Publication No. 20040029232, Issued February 12, 2004
Novel G-protein Coupled Receptors
B2Utility Patent No. 7084259, Issued August 1, 2006
Novel G-protein coupled receptors
X0Patent Application No. 10028521, Filed December 20, 2001
A1Application Publication No. 20060166309, Issued July 27, 2006
Herpes Simplex Virus Drug Screen
X0Patent Application No. 08393703, Filed February 24, 1995
B1Utility Patent No. 5585239, Issued December 17, 1996
Transcription Factor-dna Binding Assay
X0Patent Application No. 08235503, Filed April 29, 1994
B1Utility Patent No. 5563036, Issued October 8, 1996
Epstein-barr Virus Transcription Factor Binding Assay
X0Patent Application No. 08704398, Filed July 17, 1996
B1Utility Patent No. 5679525, Issued October 21, 1997
Nuclear Factors And Binding Assay
X0Patent Application No. 08396479, Filed March 2, 1995
B1Utility Patent No. 5612455, Issued March 18, 1997
Nuclear Factors And Binding Assays
X0Patent Application No. 08818823, Filed March 14, 1997
B1Utility Patent No. 5708158, Issued January 13, 1998
Interleukin 4 Signal Transducers
X0Patent Application No. 08276099, Filed July 15, 1994
B1Utility Patent No. 5591825, Issued January 7, 1997
Nucleic Acid Encoding An Interleukin 4 Signal Transducer
X0Patent Application No. 08781890, Filed January 5, 1997
B1Utility Patent No. 5710266, Issued January 20, 1998
High-throughput Screening Assay For Inhibitors Of Nucleic Acid Polymerases
X0Patent Application No. 08348797, Filed December 2, 1994
B1Utility Patent No. 5635349, Issued June 3, 1997
Interleukin-2 Signal Transducers And Binding Assays
X0Patent Application No. 08393333, Filed February 23, 1995
B1Utility Patent No. 5618693, Issued April 8, 1997
Human Signal Transducer And Binding Assays
X0Patent Application No. 08408318, Filed March 22, 1995
B1Utility Patent No. 5639858, Issued June 17, 1997
Nucleic Acid Encoding Human Signal Transducer And Activator Of Transcription 4
X0Patent Application No. 08839164, Filed April 23, 1997
B1Utility Patent No. 5756700, Issued May 26, 1998
Tnf Receptor-associated Intracellular Signaling Proteins And Methods Of Use
X0Patent Application No. 08414625, Filed March 31, 1995
B1Utility Patent No. 5563039, Issued October 8, 1996
Interleukin-1 Receptor-associated Protein Kinase And Assays
X0Patent Application No. 08587889, Filed January 16, 1996
B1Utility Patent No. 5654397, Issued August 5, 1997
C-iap 1 And C-iap 2: Inhibitors Of Apoptosis
X0Patent Application No. 08569749, Filed December 8, 1995
B1Utility Patent No. 6187557, Issued February 13, 2001
Inhibitors Of Apoptosis
X0Patent Application No. 09689366, Filed October 12, 2000
B1Utility Patent No. 6821736, Issued November 23, 2004
Inhibitors Of Apoptosis
X0Patent Application No. 10232286, Filed August 30, 2002
A1Application Publication No. 20030143579, Issued July 31, 2003
Inhibitors Of Apoptosis
B2Utility Patent No. 6855815, Issued February 15, 2005
Rip: Novel Human Protein Involved In Tumor Necrosis Factor Signal Transduction
X0Patent Application No. 09132118, Filed August 11, 1998
B1Utility Patent No. 6211337, Issued April 3, 2001
Transcriptional Promoter Of The Murine Obesity Gene
X0Patent Application No. 08558545, Filed November 16, 1995
B1Utility Patent No. 5698389, Issued December 16, 1997
Pentafluorobenzenesulfonamides And Analogs
X0Patent Application No. 08896827, Filed July 18, 1997
B1Utility Patent No. 5880151, Issued March 9, 1999
Pentafluorobenzenesulfonamides And Analogs
X0Patent Application No. 09227216, Filed January 6, 1999
B1Utility Patent No. 6121304, Issued September 19, 2000
Pentafluorobenzenesulfonamides and analogs
X0Patent Application No. 09633740, Filed August 7, 2000
B1Utility Patent No. 6316484, Issued November 13, 2001
Pentafluorobenzenesulfonamides And Analogs
X0Patent Application No. 08896280, Filed July 18, 1997
B1Utility Patent No. 6482860, Issued November 19, 2002
Substituted Benzene Compounds As Antiproliferative And Cholesterol Lowering Agents
X0Patent Application No. 08917025, Filed August 22, 1997
B1Utility Patent No. 6284923, Issued September 4, 2001
Substituted Benzene Compounds As Antiproliferative And Cholesterol Lowering Agents
X0Patent Application No. 09872463, Filed May 31, 2001
A1Application Publication No. 20020013496, Issued January 31, 2002
Substituted Benzene Compounds As Antiproliferative And Cholesterol Lowering Agents
B2Utility Patent No. 6388131, Issued May 14, 2002
High-throughput Screening Assay For Inhibitors Of Nucleic Acid Helicases
X0Patent Application No. 08616046, Filed March 14, 1996
B1Utility Patent No. 5705344, Issued January 6, 1998
Stat6 Deficient Transgenic Mice
X0Patent Application No. 08823051, Filed March 21, 1997
B1Utility Patent No. 5866760, Issued February 2, 1999
Tumor Necrosis Factor Receptor Associated Factor 6 (traf6)
X0Patent Application No. 08639237, Filed April 19, 1996
B1Utility Patent No. 5710013, Issued January 20, 1998
Novel Protein-traf6
X0Patent Application No. 08975405, Filed November 20, 1997
B1Utility Patent No. 5767244, Issued June 16, 1998
Human Telomerase Rna Interacting Protein Gene
X0Patent Application No. 08676967, Filed July 8, 1996
B1Utility Patent No. 5747317, Issued May 5, 1998
Human Telomerase Gene Rna Interacting Protein Gene
X0Patent Application No. 09072270, Filed May 4, 1998
B1Utility Patent No. 5888747, Issued March 30, 1999
Assays Using Traf2-associated Protein Kinase Polypeptides
X0Patent Application No. 08677862, Filed July 10, 1996
B1Utility Patent No. 5874230, Issued February 23, 1999
Traf2-associated Protein Kinase And Assays
X0Patent Application No. 09252571, Filed February 18, 1999
B1Utility Patent No. 5981250, Issued November 9, 1999
Traf2-associated Protein Kinase And Assays
X0Patent Application No. 09434065, Filed November 5, 1999
B1Utility Patent No. 6107074, Issued August 22, 2000
Kinase Assay
X0Patent Application No. 08702970, Filed August 26, 1996
B1Utility Patent No. 5759787, Issued June 2, 1998
Ldl Receptor Gene Expression Promoters
X0Patent Application No. 09381829, Filed September 24, 1999
B1Utility Patent No. 6159974, Issued December 12, 2000
Drug Screens For Regulators Of The Expression Of The Obese Gene
X0Patent Application No. 08707408, Filed September 4, 1996
B1Utility Patent No. 5780258, Issued July 14, 1998
Drug Screens For Regulators Of The Expression Of The Obese Gene
X0Patent Application No. 09114552, Filed July 13, 1998
B1Utility Patent No. 6432654, Issued August 13, 2002
Regulators Of Apoptosis
X0Patent Application No. 08795088, Filed February 5, 1997
B1Utility Patent No. 6242569, Issued June 5, 2001
Ikb Kinases
X0Patent Application No. 08812533, Filed March 7, 1997
B1Utility Patent No. 5837514, Issued November 17, 1998
Ikb Kinases
X0Patent Application No. 08971937, Filed November 17, 1997
B1Utility Patent No. 5776717, Issued July 7, 1998
Regulators Of Ucp2 Gene Expression
X0Patent Application No. 08846012, Filed April 25, 1997
B1Utility Patent No. 5807740, Issued September 15, 1998
Method Of Identifying Agents That Modulate Ucp2 Promoter Activity
X0Patent Application No. 09100297, Filed June 19, 1998
B1Utility Patent No. 5849514, Issued December 15, 1998
Cell-based Drug Screens For Regulators Of Gene Expression
X0Patent Application No. 08866942, Filed May 31, 1997
B1Utility Patent No. 6566089, Issued May 20, 2003
Ikk-b Proteins, Nucleic Acids And Methods
X0Patent Application No. 08890853, Filed July 10, 1997
B1Utility Patent No. 5851812, Issued December 22, 1998
Ikk-beta Proteins, Nucleic Acids And Methods
X0Patent Application No. 09099124, Filed June 17, 1998
B1Utility Patent No. 5939302, Issued August 17, 1999
Ikk-bproteins Nucleic Acids And Methods
X0Patent Application No. 09099125, Filed June 17, 1998
B1Utility Patent No. 5916760, Issued June 29, 1999
Ikk-alpha Proteins, Nucleic Acids And Methods
X0Patent Application No. 08890854, Filed July 10, 1997
B1Utility Patent No. 6235512, Issued May 22, 2001
Ikk-alpha Proteins, Nucleic Acids And Methods
X0Patent Application No. 09023324, Filed February 13, 1998
B1Utility Patent No. 6235513, Issued May 22, 2001
Ikk-a Proteins, Nucleic Acids And Methods
X0Patent Application No. 09032476, Filed February 26, 1998
B1Utility Patent No. 6235492, Issued May 22, 2001
Ikk-alpha Proteins Nucleic Acids And Methods
X0Patent Application No. 09109986, Filed July 2, 1998
B1Utility Patent No. 6479266, Issued November 12, 2002
Nucleic Acids Encoding Human Nik Protein
X0Patent Application No. 08887518, Filed July 3, 1997
B1Utility Patent No. 5843721, Issued December 1, 1998
Human Nik Protein
X0Patent Application No. 09023321, Filed February 13, 1998
B1Utility Patent No. 5844073, Issued December 1, 1998
Screening Method For Agents That Modulate Human Nik Activity
X0Patent Application No. 09032475, Filed February 26, 1998
B1Utility Patent No. 5854003, Issued December 29, 1998
Nucleic Acids Encoding Murine Ucp3 Genes
X0Patent Application No. 08937466, Filed September 25, 1997
B1Utility Patent No. 5846779, Issued December 8, 1998
Murine Ucp3 Polypeptides
X0Patent Application No. 09172528, Filed October 14, 1998
B1Utility Patent No. 5952469, Issued September 14, 1999
Murine Ucp3 Polypeptides
X0Patent Application No. 09318199, Filed May 25, 1999
B1Utility Patent No. 6025469, Issued February 15, 2000
UCP3 genes
X0Patent Application No. 09503579, Filed February 14, 2000
B1Utility Patent No. 6248561, Issued June 19, 2001
Regulators Of Ucp3 Gene Expression
X0Patent Application No. 08948277, Filed October 9, 1997
B1Utility Patent No. 5849581, Issued December 15, 1998
Assays For Identifying Agents Which Affect Regulators Of Ucp3 Gene Expression
X0Patent Application No. 09169203, Filed October 9, 1998
B1Utility Patent No. 5976808, Issued November 2, 1999
Ikap Nucleic Acids
X0Patent Application No. 08971244, Filed November 16, 1997
B1Utility Patent No. 5891719, Issued April 6, 1999
Ikap Proteins And Methods
X0Patent Application No. 09286891, Filed April 6, 1999
B1Utility Patent No. 6172195, Issued January 9, 2001
Nuclear Hormone Receptor Drug Screens
X0Patent Application No. 08975614, Filed November 21, 1997
B1Utility Patent No. 6555326, Issued April 29, 2003
Isolated Nucleic Acids Encoding Cyp7 Promoter-binding Factors
X0Patent Application No. 09132619, Filed August 11, 1998
B1Utility Patent No. 5958697, Issued September 28, 1999
Cyp7 Promoter-binding Factors
X0Patent Application No. 09282803, Filed March 31, 1999
B1Utility Patent No. 6027901, Issued February 22, 2000
Recombinant Polynucleotides Encoding Cyp7 Promoter-binding Factors
X0Patent Application No. 09510654, Filed February 22, 2000
B1Utility Patent No. 6297019, Issued October 2, 2001
Interleukin-1 Receptor Accessory Proteins, Nucleic Acids And Methods
X0Patent Application No. 08991944, Filed December 16, 1997
B1Utility Patent No. 6280955, Issued August 28, 2001
Pyrimidine Derivatives
X0Patent Application No. 09249641, Filed February 12, 1999
B1Utility Patent No. 6200977, Issued March 13, 2001
Pyrimidine Derivatives
X0Patent Application No. 09737983, Filed December 15, 2000
A1Application Publication No. 20010018436, Issued August 30, 2001
Pyrimidine Derivatives
B2Utility Patent No. 6528513, Issued March 4, 2003
Pyrimidine Derivatives
X0Patent Application No. 10350801, Filed January 24, 2003
A1Application Publication No. 20040006068, Issued January 8, 2004
Pyrimidine Derivatives
B2Utility Patent No. 6835726, Issued December 28, 2004
Benzenesulfonamides And Benzamides As Therapeutic Agents
X0Patent Application No. 09226703, Filed January 7, 1999
B1Utility Patent No. 6191170, Issued February 20, 2001
Benzenesulfonamides And Benzamides As Therapeutic Agents
X0Patent Application No. 09736040, Filed December 12, 2000
B1Utility Patent No. 6583161, Issued June 24, 2003
Ppar-gamma Modulators
X0Patent Application No. 09234327, Filed January 20, 1999
B1Utility Patent No. 6200995, Issued March 13, 2001
Ppargamma Modulators
X0Patent Application No. 09741415, Filed December 19, 2000
A1Application Publication No. 20010027200, Issued October 4, 2001
Ppargamma Modulators
B2Utility Patent No. 6620827, Issued September 16, 2003
High Throughput Screening Assays For Nucleic Acid Ligase Modulators
X0Patent Application No. 09025979, Filed February 19, 1998
B1Utility Patent No. 6153384, Issued November 28, 2000
High-throughput Screening Assays For Modulators Of Nucleic Acid Topoisomerases
X0Patent Application No. 09037154, Filed March 9, 1998
B1Utility Patent No. 5998152, Issued December 7, 1999
High-throughput Screening Assays For Modulators Of Nucleic Acid Topoisomerases
X0Patent Application No. 09351662, Filed July 13, 1999
B1Utility Patent No. 6197527, Issued March 6, 2001
High-throughput Screening Assays For Modulators Of Primase Activity
X0Patent Application No. 09052924, Filed March 31, 1998
B1Utility Patent No. 6043038, Issued March 28, 2000
High Throughput In Vitro Screening Assays For Transcription Modulators
X0Patent Application No. 09052995, Filed March 31, 1998
B1Utility Patent No. 6183956, Issued February 6, 2001
High-throughput In Vitro Assays For Modulators Of Peptidyl Transferase
X0Patent Application No. 09074580, Filed May 7, 1998
B1Utility Patent No. 5962244, Issued October 5, 1999
High-throughput Screening Assays For Modulators Of Stat4 And Stat6 Activity
X0Patent Application No. 09053003, Filed March 31, 1998
B1Utility Patent No. 6207391, Issued March 27, 2001
High-throughput Screening Assays For Modulators Of Stat4 And Stat6 Activity
X0Patent Application No. 09818094, Filed March 26, 2001
A1Application Publication No. 20020039749, Issued April 4, 2002
High-throughput Screening Assays For Modulators Of Stat4 And Stat6 Activity
B2Utility Patent No. 6682898, Issued January 27, 2004
Inhibitors Of Stat Function
X0Patent Application No. 09349208, Filed July 7, 1999
B1Utility Patent No. 6426331, Issued July 30, 2002
Suppressors Of Death Domains
X0Patent Application No. 09035676, Filed March 5, 1998
B1Utility Patent No. 6437113, Issued August 20, 2002
Sodd-specific Antibodies And Methods
X0Patent Application No. 09416213, Filed October 8, 1999
B1Utility Patent No. 6110690, Issued August 29, 2000
Methods For Detecting Sodd Genes And Proteins
X0Patent Application No. 09416214, Filed October 8, 1999
B1Utility Patent No. 6413728, Issued July 2, 2002
Suppressors Of Death Domains
X0Patent Application No. 10161346, Filed May 30, 2002
A1Application Publication No. 20030166193, Issued September 4, 2003
Suppressors Of Death Domains
B2Utility Patent No. 6838550, Issued January 4, 2005
Arylsulfonanilide phosphates
X0Patent Application No. 09595398, Filed June 14, 2000
B1Utility Patent No. 6211167, Issued April 3, 2001
Arylsulfonanilide Phosphates
X0Patent Application No. 09779419, Filed February 7, 2001
A1Application Publication No. 20010018430, Issued August 30, 2001
Arylsulfonanilide Phosphates
B2Utility Patent No. 6417176, Issued July 9, 2002
Arylsulfonanilide Derivatives
X0Patent Application No. 09353976, Filed July 15, 1999
B1Utility Patent No. 6153585, Issued November 28, 2000
Arylsulfonanilide Derivates
X0Patent Application No. 09671937, Filed September 27, 2000
B1Utility Patent No. 6630513, Issued October 7, 2003
High-throughput In Vitro Screening Assays For Modulators Of Nucleic Acid Helicases
X0Patent Application No. 09124312, Filed July 29, 1998
B1Utility Patent No. 6569619, Issued May 27, 2003
Irak3 Polypeptides And Methods
X0Patent Application No. 09135232, Filed August 17, 1998
B1Utility Patent No. 6262228, Issued July 17, 2001
Irak3 Polynucleotides
X0Patent Application No. 09863549, Filed May 22, 2001
A1Application Publication No. 20020049300, Issued April 25, 2002
Irak3 Polynucleotides
B2Utility Patent No. 6576444, Issued June 10, 2003
Arylsulfonanilide Ureas
X0Patent Application No. 09399907, Filed September 21, 1999
B1Utility Patent No. 6214880, Issued April 10, 2001
Arylsulfonanilide Ureas
X0Patent Application No. 09792669, Filed February 21, 2001
A1Application Publication No. 20010027211, Issued October 4, 2001
Arylsulfonanilide Ureas
B2Utility Patent No. 6583165, Issued June 24, 2003
Certain Polycyclic Compounds Useful As Tubulin-binding Agents
X0Patent Application No. 09464217, Filed December 15, 1999
B1Utility Patent No. 6433187, Issued August 13, 2002
Fxr Receptor-mediated Modulation Of Cholesterol Metabolism
X0Patent Application No. 09478948, Filed January 6, 2000
B1Utility Patent No. 6465258, Issued October 15, 2002
LXR modulators
X0Patent Application No. 09525861, Filed March 14, 2000
B1Utility Patent No. 6316503, Issued November 13, 2001
Compounds For The Modulation Of Ppargamma Activity
X0Patent Application No. 10209205, Filed July 30, 2002
A1Application Publication No. 20030139390, Issued July 24, 2003
Compounds For The Modulation Of Ppargamma Activity
B2Utility Patent No. 6770648, Issued August 3, 2004
Combination therapy using pentafluorobenzenesulfonamides
X0Patent Application No. 09627041, Filed July 27, 2000
B1Utility Patent No. 6355628, Issued March 12, 2002
Detection Method For Monitoring Beta Tubulin Isotype Specific Modification
X0Patent Application No. 09377554, Filed August 19, 1999
B1Utility Patent No. 6306615, Issued October 23, 2001
Modulators Of Srebp Processing
X0Patent Application No. 09680571, Filed October 6, 2000
B1Utility Patent No. 6649593, Issued November 18, 2003
Methods Of Assaying For Compounds That Inhibit Premature Translation Termination And Nonsense-mediated Rna Decay
X0Patent Application No. 09461508, Filed December 14, 1999
B1Utility Patent No. 6458538, Issued October 1, 2002
Chandra: A Novel Th1-specific Gene
X0Patent Application No. 09694094, Filed October 20, 2000
B1Utility Patent No. 6489453, Issued December 3, 2002
Sodd Gene Expression In Cancer
X0Patent Application No. 09417559, Filed October 13, 1999
B1Utility Patent No. 6372444, Issued April 16, 2002
Irak-4: Compositions And Methods Of Use
X0Patent Application No. 09759595, Filed January 11, 2001
A1Application Publication No. 20030059916, Issued March 27, 2003
Irak-4: Compositions And Methods Of Use
B2Utility Patent No. 6818419, Issued November 16, 2004
Antibacterial Agents
X0Patent Application No. 09759633, Filed January 12, 2001
A1Application Publication No. 20020045749, Issued April 18, 2002
Antibacterial Agents
B2Utility Patent No. 6780858, Issued August 24, 2004
Arylsulfonic Acid Salts Of Pyrimidine-based Antiviral
X0Patent Application No. 09757291, Filed January 8, 2001
A1Application Publication No. 20020065279, Issued May 30, 2002
Arylsulfonic Acid Salts Of Pyrimidine-based Antiviral
B2Utility Patent No. 6410726, Issued June 25, 2002
Arylsulfonic Acid Salts Of Pyrimidine-based Antiviral Agents
X0Patent Application No. 10165773, Filed June 6, 2002
A1Application Publication No. 20030045715, Issued March 6, 2003
Arylsulfonic Acid Salts Of Pyrimidine-based Antiviral Agents
B2Utility Patent No. 6599911, Issued July 29, 2003
Pyrazole Antimicrobial Agents
X0Patent Application No. 09847962, Filed May 2, 2001
A1Application Publication No. 20020049205, Issued April 25, 2002
Pyrazole Antimicrobial Agents
B2Utility Patent No. 6673923, Issued January 6, 2004
G-protein Coupled Receptors Amlified In Breast Cancer
X0Patent Application No. 09524730, Filed March 14, 2000
B1Utility Patent No. 6638733, Issued October 28, 2003
G-protein Coupled Receptor Bca-gpcr-3
X0Patent Application No. 09546986, Filed April 11, 2000
B1Utility Patent No. 6635741, Issued October 21, 2003
|
